NCT03433001View on ClinicalTrials.gov

A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone

CompletedOBSERVATIONAL
Enrollment

295

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

June 11, 2021

Study Completion Date

June 11, 2021

Conditions
Relapsed and/or Refractory Multiple Myeloma
Interventions
DRUG

Ixazomib

Ixazomib capsules

DRUG

Lenalidomide

Lenalidomide capsules

DRUG

Dexamethasone

Dexamethasone tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY